In this issue:
- Loop + thiazide diuretics for acute HF across eGFR spectrum
- Dapagliflozin for HF and deteriorating renal function
- Repurposing mirabegron for structural cardiac disease
- Natriuresis-guided diuretic therapy in acute HF
- Novel HF progression pathways
- Eliminating CaMKIIδ autophosphorylation improves HF survival and cardiac function
- GLS predicts clinical outcomes in HFPEF
- Intra-aortic entrainment pump for acute decompensated HF + cardiorenal syndrome
- Health and economic evaluation of sacubitril-valsartan in HF management
- Association of smartwatch- measured activity with patient- reported outcomes for HF
Download the Heart_Failure_Research_Review_Issue_82 with commentary by Dr Mark Nolan.

